Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt 1465.29
MED's Cash to Debt is ranked higher than
80% of the 947 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.80 vs. MED: 1465.29 )
Ranked among companies with meaningful Cash to Debt only.
MED' s Cash to Debt Range Over the Past 10 Years
Min: 0.06  Med: 1.75 Max: N/A
Current: 1465.29
Equity to Asset 0.77
MED's Equity to Asset is ranked higher than
88% of the 933 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.49 vs. MED: 0.77 )
Ranked among companies with meaningful Equity to Asset only.
MED' s Equity to Asset Range Over the Past 10 Years
Min: 0.26  Med: 0.74 Max: 0.8
Current: 0.77
0.26
0.8
Interest Coverage No Debt
MED's Interest Coverage is ranked higher than
99% of the 828 Companies
in the Global Specialty Retail industry.

( Industry Median: 26.28 vs. MED: No Debt )
Ranked among companies with meaningful Interest Coverage only.
MED' s Interest Coverage Range Over the Past 10 Years
Min: 14.77  Med: 276.75 Max: No Debt
Current: No Debt
F-Score: 9
Z-Score: 15.96
M-Score: -3.34
WACC vs ROIC
6.27%
100.75%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 9.43
MED's Operating margin (%) is ranked higher than
79% of the 945 Companies
in the Global Specialty Retail industry.

( Industry Median: 3.25 vs. MED: 9.43 )
Ranked among companies with meaningful Operating margin (%) only.
MED' s Operating margin (%) Range Over the Past 10 Years
Min: 6.82  Med: 10.56 Max: 12.28
Current: 9.43
6.82
12.28
Net-margin (%) 6.43
MED's Net-margin (%) is ranked higher than
79% of the 945 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.02 vs. MED: 6.43 )
Ranked among companies with meaningful Net-margin (%) only.
MED' s Net-margin (%) Range Over the Past 10 Years
Min: 4.58  Med: 6.46 Max: 7.61
Current: 6.43
4.58
7.61
ROE (%) 19.47
MED's ROE (%) is ranked higher than
83% of the 926 Companies
in the Global Specialty Retail industry.

( Industry Median: 6.03 vs. MED: 19.47 )
Ranked among companies with meaningful ROE (%) only.
MED' s ROE (%) Range Over the Past 10 Years
Min: 12.72  Med: 22.04 Max: 32.75
Current: 19.47
12.72
32.75
ROA (%) 14.83
MED's ROA (%) is ranked higher than
92% of the 950 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.61 vs. MED: 14.83 )
Ranked among companies with meaningful ROA (%) only.
MED' s ROA (%) Range Over the Past 10 Years
Min: 9.54  Med: 16.16 Max: 24.98
Current: 14.83
9.54
24.98
ROC (Joel Greenblatt) (%) 102.42
MED's ROC (Joel Greenblatt) (%) is ranked higher than
93% of the 946 Companies
in the Global Specialty Retail industry.

( Industry Median: 12.28 vs. MED: 102.42 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
MED' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 24.47  Med: 59.69 Max: 102.5
Current: 102.42
24.47
102.5
Revenue Growth (3Y)(%) -0.90
MED's Revenue Growth (3Y)(%) is ranked lower than
62% of the 786 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.30 vs. MED: -0.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
MED' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -45.9  Med: 28 Max: 63.7
Current: -0.9
-45.9
63.7
EBITDA Growth (3Y)(%) 4.70
MED's EBITDA Growth (3Y)(%) is ranked higher than
54% of the 663 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.70 vs. MED: 4.70 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
MED' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 4.7  Med: 24.5 Max: 78.5
Current: 4.7
4.7
78.5
EPS Growth (3Y)(%) 6.50
MED's EPS Growth (3Y)(%) is ranked higher than
58% of the 595 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.90 vs. MED: 6.50 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
MED' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -14.1  Med: 21.4 Max: 68.9
Current: 6.5
-14.1
68.9
GuruFocus has detected 2 Warning Signs with Medifast Inc $MED.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» MED's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

MED Guru Trades in Q1 2016

Paul Tudor Jones 16,900 sh (New)
Jim Simons 827,900 sh (+10.93%)
Barrow, Hanley, Mewhinney & Strauss 70,347 sh (-22.17%)
» More
Q2 2016

MED Guru Trades in Q2 2016

Paul Tudor Jones 25,100 sh (+48.52%)
Jim Simons 953,600 sh (+15.18%)
Barrow, Hanley, Mewhinney & Strauss 70,329 sh (-0.03%)
» More
Q3 2016

MED Guru Trades in Q3 2016

Barrow, Hanley, Mewhinney & Strauss Sold Out
Jim Simons 947,200 sh (-0.67%)
Paul Tudor Jones 5,722 sh (-77.20%)
» More
Q4 2016

MED Guru Trades in Q4 2016

Paul Tudor Jones 9,300 sh (+62.53%)
Jim Simons 951,500 sh (+0.45%)
» More
» Details

Insider Trades

Latest Guru Trades with MED

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Retail - Apparel & Specialty » Specialty Retail    NAICS: 445299    SIC: 2099
Compare:NYSE:VSI, NAS:ZUMZ, NYSE:PIR, NYSE:XOXO, NYSE:HZO, NYSE:BNED, NYSE:JMEI, NAS:WINA, NAS:OSTK, NAS:LE, NAS:FTD, NAS:HIBB, NAS:FLWS, NAS:FINL, NAS:PCMI, NAS:BZUN, NAS:CONN, NYSE:BKS, NYSE:SYX, NAS:BGFV » details
Traded in other countries:MDF.Germany,
Medifast Inc is engaged in the productions, distributions, and sales of weight loss and weight management products and other consumable health and diet products. Its product lines include weight loss and management, meal replacement, and vitamins.

Medifast Inc is a Delaware Corporation, incorporated in 1993. The Company is engaged in the productions, distributions, and sales of weight loss and weight management products and other consumable health and diet products. Its product lines include weight loss and management, meal replacement, and vitamins. Its products and services are sold to weight loss program participants via the Internet, telephone, and brick and mortar clinics. It operates in two reportable segments; Medifast, and MWCC and Wholesale. The Medifast segment consists of the sales from Medifast Direct Marketing and Take Shape For Life. The MWCC and Wholesale segment consists of the sales of Medifast Corporate and Franchise Weight Control Centers as well as Medifast Wholesale Physicians and international sales. Medifast Weight Control Centers is the brick and mortar clinic channel of the Company with affiliate-owned locations in Pennsylvania, New Jersey, Delaware, Texas, Florida, Maryland, North Carolina and Virginia. Medifast Weight Control Centers offer a high-touch model including comprehensive Companys programs for weight loss and maintenance, customized client counseling, an InBody body composition analysis, and monitoring with a BodyGem indirect calorimeter that determines resting metabolic rates. In the direct-to-consumer channel, Medifast Direct, customers order its product directly through the Companys website, www.medifast1.com or its in-house call center. Take Shape For Life is the personal coaching division of the Company. It enriches lives by providing clinically proven weight loss and weight management products and programs. It offers clinically proven products and programs for weight management, weight maintenance, and long-term health through multiple channels of distribution. It offers a variety of weight loss and weight management products under the Medifast and Essential 1 brands and for select private label customers. Its line includes more than 75 options, including, but not limited to bars, bites, pretzels, puffs, cereal crunch, drinks, eggs, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The Company continues to build and leverage its core brand through multiple marketing strategies for each of its distinct distribution channels such as Medifast Direct, Medical Wholesale, Medifast Weight Control Centers, and Take Shape For Life to their target audiences. It has also developed a comprehensive social media utilizing Facebook, Twitter, YouTube, blogger endorsements, and more. The Company competes with NutriSystem Inc., Herbalife Ltd., USANA Health Sciences, and Weight Watchers International, Inc. The formulation, processing, packaging, and labeling of the Company's products is subject to regulation by several federal agencies, but principally by the FDA.

Top Ranked Articles about Medifast Inc

Director Boosts Stake in Sears as Retail Companies Become Hot Buys Retail stocks demonstrate high performance and profitability
On June 1, Bruce Berkowitz (Trades, Portfolio) of Fairholme Capital Management increased his Sears Holding Group (NASDAQ:SHLD) holding by 2.78%, buying the additional shares at an average price of $12.50 per share. The fund also made a $10.13 billion insider transaction, buying 778,000 shares of Sears’ stock at an average price of $13.02 per share. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 30.77
MED's P/E(ttm) is ranked lower than
71% of the 770 Companies
in the Global Specialty Retail industry.

( Industry Median: 21.00 vs. MED: 30.77 )
Ranked among companies with meaningful P/E(ttm) only.
MED' s P/E(ttm) Range Over the Past 10 Years
Min: 8.97  Med: 20.87 Max: 61.23
Current: 30.77
8.97
61.23
PE(NRI) 30.57
MED's PE(NRI) is ranked lower than
71% of the 705 Companies
in the Global Specialty Retail industry.

( Industry Median: 20.41 vs. MED: 30.57 )
Ranked among companies with meaningful PE(NRI) only.
MED' s PE(NRI) Range Over the Past 10 Years
Min: 8.97  Med: 19.35 Max: 61.23
Current: 30.57
8.97
61.23
Price/Owner Earnings (ttm) 43.02
MED's Price/Owner Earnings (ttm) is ranked lower than
79% of the 451 Companies
in the Global Specialty Retail industry.

( Industry Median: 19.99 vs. MED: 43.02 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
MED' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 7.61  Med: 22.32 Max: 201.3
Current: 43.02
7.61
201.3
P/B 5.69
MED's P/B is ranked lower than
85% of the 1015 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.76 vs. MED: 5.69 )
Ranked among companies with meaningful P/B only.
MED' s P/B Range Over the Past 10 Years
Min: 1.36  Med: 4.02 Max: 10.94
Current: 5.69
1.36
10.94
P/S 1.98
MED's P/S is ranked lower than
78% of the 1002 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.72 vs. MED: 1.98 )
Ranked among companies with meaningful P/S only.
MED' s P/S Range Over the Past 10 Years
Min: 0.49  Med: 1.3 Max: 4.73
Current: 1.98
0.49
4.73
PFCF 22.12
MED's PFCF is ranked lower than
59% of the 457 Companies
in the Global Specialty Retail industry.

( Industry Median: 16.40 vs. MED: 22.12 )
Ranked among companies with meaningful PFCF only.
MED' s PFCF Range Over the Past 10 Years
Min: 8.42  Med: 15.87 Max: 139.65
Current: 22.12
8.42
139.65
POCF 19.55
MED's POCF is ranked lower than
73% of the 584 Companies
in the Global Specialty Retail industry.

( Industry Median: 10.88 vs. MED: 19.55 )
Ranked among companies with meaningful POCF only.
MED' s POCF Range Over the Past 10 Years
Min: 5.44  Med: 12.54 Max: 51.95
Current: 19.55
5.44
51.95
EV-to-EBIT 17.73
MED's EV-to-EBIT is ranked lower than
57% of the 827 Companies
in the Global Specialty Retail industry.

( Industry Median: 15.49 vs. MED: 17.73 )
Ranked among companies with meaningful EV-to-EBIT only.
MED' s EV-to-EBIT Range Over the Past 10 Years
Min: 4.8  Med: 11.5 Max: 38.8
Current: 17.73
4.8
38.8
EV-to-EBITDA 14.46
MED's EV-to-EBITDA is ranked lower than
60% of the 872 Companies
in the Global Specialty Retail industry.

( Industry Median: 11.90 vs. MED: 14.46 )
Ranked among companies with meaningful EV-to-EBITDA only.
MED' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.9  Med: 8.7 Max: 29.4
Current: 14.46
3.9
29.4
PEG 6.86
MED's PEG is ranked lower than
82% of the 295 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.26 vs. MED: 6.86 )
Ranked among companies with meaningful PEG only.
MED' s PEG Range Over the Past 10 Years
Min: 0.22  Med: 0.79 Max: 9.08
Current: 6.86
0.22
9.08
Shiller P/E 40.06
MED's Shiller P/E is ranked lower than
76% of the 247 Companies
in the Global Specialty Retail industry.

( Industry Median: 21.22 vs. MED: 40.06 )
Ranked among companies with meaningful Shiller P/E only.
MED' s Shiller P/E Range Over the Past 10 Years
Min: 21.68  Med: 34.75 Max: 106.67
Current: 40.06
21.68
106.67
Current Ratio 3.97
MED's Current Ratio is ranked higher than
89% of the 913 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.57 vs. MED: 3.97 )
Ranked among companies with meaningful Current Ratio only.
MED' s Current Ratio Range Over the Past 10 Years
Min: 0.99  Med: 3.31 Max: 6.73
Current: 3.97
0.99
6.73
Quick Ratio 3.39
MED's Quick Ratio is ranked higher than
92% of the 912 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.83 vs. MED: 3.39 )
Ranked among companies with meaningful Quick Ratio only.
MED' s Quick Ratio Range Over the Past 10 Years
Min: 0.46  Med: 2.31 Max: 4.52
Current: 3.39
0.46
4.52
Days Inventory 67.91
MED's Days Inventory is ranked higher than
60% of the 886 Companies
in the Global Specialty Retail industry.

( Industry Median: 88.95 vs. MED: 67.91 )
Ranked among companies with meaningful Days Inventory only.
MED' s Days Inventory Range Over the Past 10 Years
Min: 67.91  Med: 93.93 Max: 165.97
Current: 67.91
67.91
165.97
Days Sales Outstanding 1.51
MED's Days Sales Outstanding is ranked higher than
91% of the 721 Companies
in the Global Specialty Retail industry.

( Industry Median: 13.41 vs. MED: 1.51 )
Ranked among companies with meaningful Days Sales Outstanding only.
MED' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0.88  Med: 1.96 Max: 2.46
Current: 1.51
0.88
2.46

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 2.36
MED's Dividend Yield is ranked higher than
53% of the 960 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.27 vs. MED: 2.36 )
Ranked among companies with meaningful Dividend Yield only.
MED' s Dividend Yield Range Over the Past 10 Years
Min: 0.81  Med: 2.2 Max: 2.75
Current: 2.36
0.81
2.75
Dividend Payout 0.68
MED's Dividend Payout is ranked lower than
72% of the 552 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.45 vs. MED: 0.68 )
Ranked among companies with meaningful Dividend Payout only.
MED' s Dividend Payout Range Over the Past 10 Years
Min: 0.15  Med: 0.15 Max: 0.68
Current: 0.68
0.15
0.68
Forward Dividend Yield 2.83
MED's Forward Dividend Yield is ranked higher than
60% of the 921 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.39 vs. MED: 2.83 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 2.36
MED's Yield on cost (5-Year) is ranked lower than
57% of the 1188 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.91 vs. MED: 2.36 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
MED' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.81  Med: 2.2 Max: 2.75
Current: 2.36
0.81
2.75
3-Year Average Share Buyback Ratio 5.00
MED's 3-Year Average Share Buyback Ratio is ranked higher than
92% of the 494 Companies
in the Global Specialty Retail industry.

( Industry Median: -0.40 vs. MED: 5.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MED' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -20.4  Med: -7.6 Max: 8
Current: 5
-20.4
8

Valuation & Return

vs
industry
vs
history
Price/Net Cash 10.07
MED's Price/Net Cash is ranked higher than
57% of the 135 Companies
in the Global Specialty Retail industry.

( Industry Median: 12.98 vs. MED: 10.07 )
Ranked among companies with meaningful Price/Net Cash only.
MED' s Price/Net Cash Range Over the Past 10 Years
Min: 7.48  Med: 18.13 Max: 382.25
Current: 10.07
7.48
382.25
Price/Net Current Asset Value 7.23
MED's Price/Net Current Asset Value is ranked lower than
60% of the 546 Companies
in the Global Specialty Retail industry.

( Industry Median: 4.67 vs. MED: 7.23 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
MED' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 5.25  Med: 9.79 Max: 164.67
Current: 7.23
5.25
164.67
Price/Tangible Book 5.68
MED's Price/Tangible Book is ranked lower than
79% of the 932 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.12 vs. MED: 5.68 )
Ranked among companies with meaningful Price/Tangible Book only.
MED' s Price/Tangible Book Range Over the Past 10 Years
Min: 1.1  Med: 3.98 Max: 24.19
Current: 5.68
1.1
24.19
Price/Projected FCF 1.74
MED's Price/Projected FCF is ranked lower than
61% of the 493 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.35 vs. MED: 1.74 )
Ranked among companies with meaningful Price/Projected FCF only.
MED' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.99  Med: 2.72 Max: 11.38
Current: 1.74
0.99
11.38
Price/DCF (Earnings Based) 1.07
MED's Price/DCF (Earnings Based) is ranked higher than
53% of the 98 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.11 vs. MED: 1.07 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.53
MED's Price/Median PS Value is ranked lower than
79% of the 860 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.04 vs. MED: 1.53 )
Ranked among companies with meaningful Price/Median PS Value only.
MED' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.18  Med: 1.02 Max: 4.72
Current: 1.53
0.18
4.72
Price/Graham Number 2.78
MED's Price/Graham Number is ranked lower than
73% of the 645 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.54 vs. MED: 2.78 )
Ranked among companies with meaningful Price/Graham Number only.
MED' s Price/Graham Number Range Over the Past 10 Years
Min: 0.35  Med: 1.89 Max: 6.25
Current: 2.78
0.35
6.25
Earnings Yield (Greenblatt) (%) 5.67
MED's Earnings Yield (Greenblatt) (%) is ranked higher than
55% of the 1047 Companies
in the Global Specialty Retail industry.

( Industry Median: 5.27 vs. MED: 5.67 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MED' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 2.6  Med: 8.7 Max: 20.7
Current: 5.67
2.6
20.7
Forward Rate of Return (Yacktman) (%) 7.48
MED's Forward Rate of Return (Yacktman) (%) is ranked higher than
61% of the 544 Companies
in the Global Specialty Retail industry.

( Industry Median: 3.67 vs. MED: 7.48 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
MED' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 7.48  Med: 27.8 Max: 47.3
Current: 7.48
7.48
47.3

More Statistics

Revenue (TTM) (Mil) $273.4
EPS (TTM) $ 1.48
Beta0.51
Short Percentage of Float4.40%
52-Week Range $27.64 - 45.95
Shares Outstanding (Mil)11.85

Analyst Estimate

Dec16
Revenue (Mil $)
EPS ($) 1.82
EPS w/o NRI ($) 1.82
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for MED

Headlines

Articles On GuruFocus.com
Piotroski F-Score Study: Specialty Retail Companies Offer Hot Buys Jul 06 2016 
Insiders Roundup: Buys of Advance Auto Parts, Sales of Fitbit Jun 03 2016 
Director Boosts Stake in Sears as Retail Companies Become Hot Buys Jun 02 2016 
Guru Stocks With Strong 10-Year Returns May 12 2016 
NutriSystem Stock Surges On Upbeat Q4 2014 Results Mar 04 2015 
This Company Focuses on Consumer Preferences in the Entire World Dec 17 2014 
Is It Time to Buy Avon? Dec 11 2014 
Small cap high short interest (Predictability = 5), Part 1 Oct 16 2014 
Should You Stay Away From Avon? Sep 30 2014 
How Are GuruFocus Model Portfolios Faring Beside the Market in 2012? Dec 28 2012 

More From Other Websites
Take Shape For Life® Hosts Largest Go Global Leadership Conference Ever Feb 20 2017
Medifast, Inc. – Value Analysis (NYSE:MED) : January 18, 2017 Jan 18 2017
ETFs with exposure to Medifast, Inc. : January 17, 2017 Jan 17 2017
Medifast, Inc. breached its 50 day moving average in a Bearish Manner : MED-US : January 13, 2017 Jan 13 2017
MEDIFAST INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jan 10 2017
Medifast, Inc. to Participate in the 19th Annual ICR Conference Jan 03 2017
Year in Review 2016: How Baltimore area public companies fared in 2016 Dec 22 2016
Medifast, Inc. Announces 28 Percent Increase in Quarterly Dividend Dec 08 2016
MEDIFAST INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 08 2016
Medifast Inc (MED): Are Hedge Funds Right About This Stock? Dec 06 2016
Medifast Executive Chairman, Michael MacDonald, Recognized as an NACD® Board Leadership Fellow Dec 02 2016
5 Medical Tech Stocks You Should Be Investing In Dec 01 2016
Medifast, Inc. breached its 50 day moving average in a Bearish Manner : MED-US : December 1, 2016 Dec 01 2016
ETFs with exposure to Medifast, Inc. : November 23, 2016 Nov 23 2016
Medifast, Inc. :MED-US: Earnings Analysis: Q3, 2016 By the Numbers : November 22, 2016 Nov 22 2016
MEDIFAST INC Financials Nov 17 2016
MEDIFAST INC Files SEC form 10-Q, Quarterly Report Nov 09 2016
ETF’s with exposure to Medifast, Inc. : November 8, 2016 Nov 08 2016
Medifast, Inc. breached its 50 day moving average in a Bearish Manner : MED-US : November 7, 2016 Nov 07 2016
Edited Transcript of MED earnings conference call or presentation 3-Nov-16 8:30pm GMT Nov 04 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)